WallStSmart

HCA Healthcare, Inc. (HCA)vsNutex Health Inc (NUTX)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

HCA Healthcare, Inc. generates 9114% more annual revenue ($78.01B vs $846.72M). NUTX leads profitability with a 21.2% profit margin vs 8.8%. NUTX trades at a lower P/E of 7.5x. HCA earns a higher WallStSmart Score of 65/100 (C+).

HCA

Buy

65

out of 100

Grade: C+

Growth: 6.0Profit: 8.0Value: 5.3Quality: 6.0
Piotroski: 5/9Altman Z: 1.71

NUTX

Buy

63

out of 100

Grade: C+

Growth: 7.3Profit: 9.5Value: 8.3Quality: 7.5
Piotroski: 4/9Altman Z: 2.49
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

HCASignificantly Overvalued (-76.5%)

Margin of Safety

-76.5%

Fair Value

$301.11

Current Price

$426.94

$125.83 premium

UndervaluedFair: $301.11Overvalued
NUTXUndervalued (+61.7%)

Margin of Safety

+61.7%

Fair Value

$269.07

Current Price

$200.24

$68.83 discount

UndervaluedFair: $269.07Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

HCA5 strengths · Avg: 9.0/10
Return on EquityProfitability
136.3%10/10

Every $100 of equity generates 136 in profit

Debt/EquityHealth
-7.4210/10

Conservative balance sheet, low leverage

Market CapQuality
$92.43B9/10

Large-cap with strong market position

P/E RatioValuation
14.3x8/10

Attractively priced relative to earnings

Free Cash FlowQuality
$1.10B8/10

Generating 1.1B in free cash flow

NUTX5 strengths · Avg: 9.6/10
P/E RatioValuation
7.5x10/10

Attractively priced relative to earnings

Operating MarginProfitability
57.8%10/10

Strong operational efficiency at 57.8%

EPS GrowthGrowth
95.9%10/10

Earnings expanding 95.9% YoY

Return on EquityProfitability
27.8%9/10

Every $100 of equity generates 28 in profit

Profit MarginProfitability
21.2%9/10

Keeps 21 of every $100 in revenue as profit

Areas to Watch

HCA1 concerns · Avg: 4.0/10
Altman Z-ScoreHealth
1.714/10

Distress zone — elevated risk

NUTX2 concerns · Avg: 2.5/10
Market CapQuality
$1.32B3/10

Smaller company, higher risk/reward

Revenue GrowthGrowth
-13.6%2/10

Revenue declined 13.6%

Comparative Analysis Report

WallStSmart Research

Bull Case : HCA

The strongest argument for HCA centers on Return on Equity, Debt/Equity, Market Cap. PEG of 1.29 suggests the stock is reasonably priced for its growth.

Bull Case : NUTX

The strongest argument for NUTX centers on P/E Ratio, Operating Margin, EPS Growth. Profitability is solid with margins at 21.2% and operating margin at 57.8%.

Bear Case : HCA

The primary concerns for HCA are Altman Z-Score.

Bear Case : NUTX

The primary concerns for NUTX are Market Cap, Revenue Growth.

Key Dynamics to Monitor

HCA profiles as a value stock while NUTX is a declining play — different risk/reward profiles.

NUTX carries more volatility with a beta of 2.02 — expect wider price swings.

HCA is growing revenue faster at 8.7% — sustainability is the question.

HCA generates stronger free cash flow (1.1B), providing more financial flexibility.

Bottom Line

HCA scores higher overall (65/100 vs 63/100). NUTX offers better value entry with a 61.7% margin of safety. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

HCA Healthcare, Inc.

HEALTHCARE · MEDICAL CARE FACILITIES · USA

HCA Healthcare is an American for-profit operator of health care facilities that was founded in 1968. It is based in Nashville, Tennessee, and, as of May 2020, owns and operates 186 hospitals and approximately 2,000 sites of care, including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics in 21 states and the United Kingdom.

Visit Website →

Nutex Health Inc

HEALTHCARE · MEDICAL CARE FACILITIES · USA

Nutex Health, Inc. is a technology-based healthcare services company. The company is headquartered in Houston, Texas.

Want to dig deeper into these stocks?